Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

NCT04526730

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

NCT01972347

Conditions: Body Temperature Changes, Fever, Melanoma, +13 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Completed

Digital Phenotyping of Psychological Distress in Skin Cancer Patients

NCT07670403

Conditions: Basal Cell Carcinoma of Skin, Behavior, Behavioral Symptoms, +25 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts

NCT05712551

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations: Herlev University Hospital Herlev, Denmark

View Trial Details

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions: Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 148 locations

View Trial Details

Completed

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer

NCT05380336

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +23 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Completed

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

NCT05708950

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +76 more
Locations: UCLA Health (Santa Monica Cancer Care) Santa Monica, California, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Sarah Cannon Research Institute at Florida Cancer Specialists Sarasota, Florida, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

A Study of Patient Characteristics and Treatment Patterns in Real-world Melanoma Patients Treated With Dabrafenib and Trametinib or Encorafenib and Binimetinib in Japan

NCT07649252

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Novartis Pharma K.K. Tokyo, Japan

View Trial Details

Completed

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

NCT07651020

Conditions: Adnexal Diseases, Astrocytoma, Breast Cancer, +54 more
Locations: Wuhan Union Hospital, China Wuhan, Hubei, China

View Trial Details

Completed

New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy

NCT03136783

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: CHU Amiens Picardie Amiens, Picardie, France

View Trial Details